Another aspect of TERT promoter mutation is that this alteration without accompanying IDH mutation suggests clinically and biologically aggressive characteristics comparable with those of glioblastomas when found in histologically diagnosed as diffuse gliomas [6]. This evidence concerns the gene IDH1 and glioblastoma.